相关实验视频

Updated: Jan 16, 2026

Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug

Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug

Published on: December 14, 2021

达萨替尼与蒂莫金的药物相互作用:大鼠的药理学研究

Ajaz Ahmad¹, Mohammad Raish², Khalid M Alkharfy¹

¹Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

International journal of medical sciences

|October 6, 2025

概括

蒂莫金 (TQ) 通过抑制其新陈代谢和运输,显著增加大沙替尼 (DAS) 在老鼠中的水平. 这种相互作用可能会改变药物的疗效和毒性,需要谨慎同时使用.

科学领域:

药理学和毒理学药理学和毒理学
药物代谢和药理动力学
自然产品的相互作用

背景情况:

达沙替尼 (DAS) 是用于白血病治疗的关键多酶抑制剂.
DAS由CYP3A4代谢,并由P-糖蛋白 (Pgp) 和乳腺癌抗性蛋白 (BCRP) 运输,使其容易发生相互作用.
蒂莫金 (TQ) 是一种天然化合物,具有潜在的治疗用途,但其与DAS的相互作用是未知的.

研究的目的:

在大鼠中研究基诺 (TQ) 对达沙替尼 (DAS) 药理动力学 (PK) 的影响.
探索TQ对关键药物代谢和运输蛋白的表达的影响.
评估TQ和DAS之间药物草药相互作用的可能性.

主要方法:

在一次口服DAS (25 mg/kg) 单剂量之前,Wistar大鼠接受了TQ (40 mg/kg/天) 的预治疗一周.
使用UPLC-MS/MS测量了血DAS度,并通过非分区分析计算了PK参数.
分析了肝脏和肠道CYP3A4,PGP和BCRP蛋白质表达,使用了西班牙的Western blot.

主要成果:

治疗前的TQ显著增加了DAS Cmax (213.26%),AUC0-t (166.53%) 和Tmax (83.33%),同时降低了VD (67.70%) 和CL (36.35%).
在肝脏和肠道组织中,TQ显著抑制了CYP3A4,PGP和BCRP1蛋白质的表达.
这些变化表明,由于TQ对关键蛋白质的调节作用,DAS生物可用性增加.

结论:

提摩诺的预处理显著改变了大萨替尼布在老鼠中的处置,可能会增加其生物可用性.
TQ抑制CYP3A4,Pgp和BCRP1,导致达沙替尼的清除率降低,血度增加.
同时服用含有TQ的产品和达沙替尼可能会导致显著的药物相互作用,可能会影响疗效和毒性.

关键词:

BCPR. 这是.在CYP3A2中.达沙替尼布 (Dasatinib) 是一种在Pgp中,Pgp是指Pgp的意思.互动互动互动互动互动.药物动力学药物动力学这种药物是thymoquinone.

更多相关视频

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

相关概念视频

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...

Pharmacokinetics: Drug–Drug Interactions

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...